Stock listing
NASDAQ:SNSS Sunesis Pharmaceuticals Inc Stock
Follow Sunesis Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:SNSS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SNSS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sunesis Pharmaceuticals Inc on 6ix
- Decks
- 11 decks · latest Oct 4, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Viracta Therapeutics — Investor Presentation (October 2023) | Investor deck | 47 slides | Oct 4, 2023 |
| Viracta Therapeutics — Corporate Update (August 2021) | Corporate update | 34 slides | Aug 12, 2021 |
| Viracta Therapeutics — Investor Presentation (April 2021) | Investor deck | 24 slides | Apr 14, 2021 |
| Merger or Acquisition (January 2021) | Merger or acquisition | 23 slides | Jan 7, 2021 |
| Merger or Acquisition (November 2020) | Merger or acquisition | 11 slides | Nov 30, 2020 |
| Investor Presentation (March 2020) | Investor deck | 33 slides | Mar 18, 2020 |
| JPM Healthcare Conference 2020 | Conference | 32 slides | Jan 13, 2020 |
| Investor Presentation (July 2019) | Investor deck | 27 slides | Jul 10, 2019 |
| JPMorgan Healthcare Conference 2019 | Conference | 30 slides | Jan 7, 2019 |
| Investor Presentation (June 2007) | Investor deck | 31 slides | June 2007 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2006) | Investor deck | 31 slides | September 2006 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Stump Other companies: Regenxbio Inc. (Independent Board Member · Since at least Oct 14, 2015); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Portola Pharmaceuticals Inc (Director · Sep 24, 2015 – Jul 2, 2020 · Past); Dendreon Corp (Director · Jun 2, 2010 – Jan 3, 2014 · Past); Human Genome Sciences Inc (Exec. Vice President · Mar 10, 2009 – Jul 30, 2012 · Past) | Director · Jun 18, 2009 – Jun 30, 2020 · Past |
| Henry Ward Wolff Other companies: Calithera Biosciences, Inc. (Director · Dec 2, 2014 – Jun 1, 2022 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jul 2, 2020 · Past); Oruka Therapeutics, Inc. (Sr. VP Finance and CFO · Jul 24, 2006 – Feb 1, 2007 · Past); Sangamo Therapeutics, Inc. (Exec VP & CFO · Jun 7, 2006 – Dec 12, 2016 · Past); Abgenix Inc (CFO & SVP, Finance · Mar 24, 2006 – Apr 1, 2006 · Past) | Director · Feb 2, 2018 – Jun 30, 2020 · Past |
| Edward Hurwitz Other companies: Dyne Therapeutics, Inc. (Director · Since at least Jul 31, 2020); MacroGenics, Inc. (Director · Since at least Oct 9, 2013); Turmeric Acquisition Corp (Chief Financial Officer · Oct 15, 2020 – Oct 15, 2020 · Past); Tvardi Therapeutics, Inc. (Director · Jan 30, 2014 – Feb 5, 2014 · Past) | Director · Apr 3, 2009 – Jun 28, 2013 · Past |
| Nicole Onetto Other companies: Bolt Biotherapeutics, Inc. (Director · Since at least Dec 14, 2021); Viracta Therapeutics Inc (Director · Mar 26, 2021 – Jun 9, 2022 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jun 11, 2019 · Past); ImmunoGen Inc (Director · Nov 12, 2013 – Nov 10, 2015 · Past) | Director · Sep 17, 2019 – Jun 30, 2020 · Past |
| Adam Craig Other companies: X4 Pharmaceuticals, Inc. (Executive Chair · Since at least Aug 12, 2025); CTi Biopharma Corp (President and CEO, Director · Mar 20, 2017 – Jun 26, 2023 · Past) | EVP, Development & CMO · Feb 27, 2012 – Feb 27, 2015 · Past |
| Bob McDowell Other companies: Kardigan, Inc. (Co-Founder and Scientific Adviser · Since at least Nov 5, 2026); MyoKardia Inc (Chief Scientific Officer · Oct 28, 2015 – Nov 17, 2020 · Past) | Vice President, Research · Sep 11, 2007 – Sep 13, 2007 · Past |
| Dayton Misfeldt Other companies: Interleukin Genetics Inc (Director · May 17, 2013 – May 17, 2013 · Past) | See Remarks, Director · Apr 3, 2009 – Jun 30, 2020 · Past |
| Steve Carchedi Other companies: Allarity Therapeutics, Inc. (Chief Executive Officer, Director · Dec 20, 2021 – Dec 20, 2021 · Past) | Director · Jun 20, 2013 – Jun 30, 2020 · Past |
| Steven B Ketchum Other companies: Amarin Corporation plc (EVP, Chief Scientific Officer · Since at least Oct 5, 2017) | Director · Jun 29, 2018 – Jun 30, 2020 · Past |
| Valerie L Pierce Other companies: NGM Biopharmaceuticals Inc (See Remarks · Mar 3, 2021 – Mar 26, 2024 · Past) | SVP & General Counsel · Apr 16, 2007 – Jun 30, 2008 · Past |
All 15 people
| Person | Seat |
|---|---|
| William P Quinn Other companies: Bolt Biotherapeutics, Inc. (President, CEO and CFO, Director · Since at least Feb 4, 2021) | See Remarks · Nov 30, 2017 – Mar 31, 2020 · Past |
| Daryl B Winter | SVP of I.P./Corp. Secretary · Nov 30, 2006 – Nov 30, 2006 · Past |
| James W Young | Director · Jun 29, 2012 – Jun 30, 2020 · Past |
| Judith A Fox | See Remarks · Mar 14, 2019 – Mar 31, 2020 · Past |
| Matthew Fust | Director · Jun 28, 2013 – Jun 30, 2016 · Past |
Log in to ask 6ix AI your own questions about Sunesis Pharmaceuticals Inc.